CANCER EPIDEMIOLOGY RESEARCH IN I NDONESIA, BASED ON RISKESDAS

National Institute Health Research & Development Ministry of Health

Data sources
• Riskesdas (Basic National health research) 2007 • Susenas (National social economic survey) 2007

Sample
• 33 provinces in Indonesia • All ages • Samples of Riskesdas and Susenas  same samples

Riskesdas 2007 vs 2010
Riskesdas 2007
Household Samples
Representation Sample unit

Riskesdas 2010
70 000
Provice, national BS

280 000
District, prov, national BS (census block)

Total of PH BS
Total of biomedical BS

18000
971 (cities)

2800
823

Choosing Sample BS Total households/BS
Collected Data

Same with BS susenas 16
Complete : behavior, Nutrition, Com dis, Non com dis, disabilities, MCH

Core of Population Census 2010 25
Focus on MDG’s health indicators kesehatan and determinants

Biomedical samples

complete

Malaria & Tb

Notes
• Not elaborating tumor specification • Not elaborating tumor’s origin • Positive tumor if based on health worker’s diagnosis • Not mentioning tumor’s onset • The rate were in per mil (0/00)

12.0

10.0

2.0

4.0

6.0

8.0

0.0
DI Yogyakarta

9,6

Jawa Tengah DKI Jakarta

Banten
Sulawesi Utara Sumatera Barat Jawa Barat Bali Sulawesi Selatan Sulawesi Tengah Jawa Timur Kalimantan Selatan Kepulauan Riau Kalimantan Tengah Bengkulu Lampung Kalimantan Timur Papua

Riau
Jambi Nusa Tenggara Timur Gorontalo

Sumatera Utara
Nusa Tenggara Barat Papua Barat

4,3

NAD Sulawesi Tenggara Kalimantan Barat Sulawesi Barat Bangka Belitung Sumatera Selatan Maluku Utara

Tumor’s prevalence per Province, RKD 2007 (0/00)

1,5

Maluku

Tumor’s prevalence for ages group, RKD 2007 (0/00)
10 9 8 7 6 5 4 3 2 1 0
<1 1-4 5-14 15-24 25-34 35-44 45-54 55-64 65-74 75+

Tumor’s prevalence for Sex & place, RKD 2007 (0/00)
6 5 6 5 4 3 2 1 0 Laki-Laki Perempuan Kota Desa

4 3
2 1

0

Tumor’s prevalence for education, RKD 2007 (0/00)
9
8

7
6

5
4

3
2 1 0

Tidak Sekolah

Tidak Tamat SD

Tamat SD

Tamat SMP Tamat SMA

Tamat PT

Tumor’s prevalence for occupation, RKD 2007 (0/00)
9 8 7 6 5 4 3 2 1 0

Tumor’s prevalence for Economic status, RKD 2007 (0/00)
7
6 5 4

3 2
1 0

Kuintil-1

Kuintil-2

Kuintil-3

Kuintil-4

Kuintil-5

STRUKTUR ORGANISASI BADAN PENELITIAN, PENGEMBANGAN KESEHATAN DAN PENAPISAN TEKNOLOGI KESEHATAN

BADAN PENELITIAN, PENGEMBANGAN KESEHATAN DAN PENAPISAN TEKNOLOGI KESEHATAN

SEKRETARIAT BADAN

PUSAT PENELITIAN DAN PENGEMBANGAN BIOMEDIS DAN TEKONOLOGI DASAR KESEHATAN

PUSAT PENELITIAN DAN PENGEMBANGAN TEKNOLOGI KESEHATAN TERAPAN DAN EPIDEMIOLOGI KLINIK

PUSAT PENELITIAN DAN PENGEMBANGAN TEKNOLOGI INTERVENSI KESEHATAN MASYARAKAT

PUSAT PENELITIAN DAN PENGEMBANGAN HUMANIORA, KEBIJAKAN KESEHATAN DAN PEMBERDAYAAN MASYARAKAT

100

75

80

85

90

95

96.66

95.6

Manfaat Jamu/Obat Tradisional Menurut Provinsi

Kemanfaatan : 95,6% merasakan manfaat ( 83,23 – 96,66%)

MALUT BALI KALSEL NAD INDONESIA NTB KALBAR MALUKU KEPRI JATIM LAMPUNG JAMBI SUMUT JATENG SUMSEL SULBAR BANTEN JABAR KALTENG DKI BABEL DIY KALTIM RIAU BENGKULU SULTENG SULTRA GORONTALO PABAR NTT SULSEL SULUT PAPUA SUMBAR

83.23

84

86

88

90

92

94

96

15-24 25-34 35-44 45-54 55-64 65-74 75+

Laki laki Perempuan
Perkotaan Perdesaan Tidak sekolah Tidak tamat SD Tamat SD Tamat SMP Tamat SMA Tamat PT Tidak kerja Sekolah TNI/POLRI Pegawai /PNS Pelayan jasa/dagang Buruh/tani/nelayan Lainnya Kuintil 1 Kuintil 2 Kuintil 3 Kuintil 4 Kuintil 5

Merasakan Manfaat Jamu/Obat Tradisional Menurut Karakteristik

PROGRAM UNIT UTAMA (DIT/SUBDIT DLL)

6 PROGRAM LITBANGKES (RENSTRA-RPJMN 2009 – 14)

+ VALUE BASED

•KELEMBAGAAN •PERORANGAN

SASARAN PROGRAM KEMKES TERCAPAI TANPA MALPRAKTEK

Pindah jabfung lit: < 45 tahun

Profesor Riset

Conclusion
• The recent cancer epidemiology data of national level submitted by NIHRD • NIHRD act as an executive agency conducting National Basic Health research in RI periodically • NIHRD also act as the cooordinator of national research and development by implementing the scheme of ad hoc researcher and collaborating with univeristy and teahing hospital’s researchers, developing master and PhD by research.

Master your semester with Scribd & The New York Times

Special offer for students: Only $4.99/month.

Master your semester with Scribd & The New York Times

Cancel anytime.